Screening for fetal abnormalities:: From a health technology assessment report to a national statue

被引:7
作者
Autti-Raemoe, Ilona
Maekelae, Marjukka
机构
[1] STAKES, Finnish Off Hlth Care Technol Assessment Finohta, Helsinki 00530, Finland
[2] Univ Copenhagen, Dept Gen Practice, DK-1014 Copenhagen K, Denmark
关键词
screening; health policy; prenatal; pregnancy; fetus; chromosome abnormalities; malformation;
D O I
10.1017/S0266462307070663
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Previously in Finland, each municipality selected which methods to use in screening for fetal abnormalities. This resulted in practice variation and inequity. The national health technology assessment (HTA) office Finohta compared the methods and time frames available when screening for chromosomal and structural abnormalities. The assessment identified a need to discuss several value-laden questions before policy decisions could be taken. Methods: The National Screening Committee (NSC) at the Ministry of Health and Social Affairs (MOH) formulated a statement based on the HTA report to inform policy makers. This article describes the steps in the policy process. Results: The national screening committee organized an open forum to discuss the ethically relevant aspects of fetal screening, and a lengthy public discussion highlighted the viewpoints of various stakeholders. Based on the assessment, public discussion, and several committee meetings that heard further experts, the NSC formulated a conclusion based on equity of access. This also offered options for families unwilling to terminate a pregnancy due to fetal abnormality. The MOH sent the conclusion to a comment round, and the proposal was accepted with minor adjustments. The Ministry decided to unify the regulation of all public screening programs by one statute. The policy process lasted three years, and the methods to screen for fetal abnormalities will be unified after a further 3 years. Conclusions: The assessment of screening programs for fetal abnormalities reached beyond its original mandate. The process of examining values behind screening resulted in a program that respects the differing objectives and ethical values of pregnant families, and to national legislation on screening programs.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 12 条
[1]   Expanding screening for rare metabolic disease in the newborn:: An analysis of costs, effect and ethical consequences for decision-making in Finland [J].
Autti-Rämö, I ;
Mäkelä, M ;
Sintonen, H ;
Koskinen, H ;
Laajalahti, L ;
Halila, R ;
Käariäinen, H ;
Lapatto, R ;
Näntö-Salonen, K ;
Pulkki, K ;
Renlund, M ;
Salo, M ;
Tyni, T .
ACTA PAEDIATRICA, 2005, 94 (08) :1126-1136
[2]   Ethical evaluation in health technology assessment reports:: An eclectic approach [J].
Autti-Ramo, Ilona ;
Makela, Marjukka .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) :1-8
[3]  
AUTTIRAMO I, 2006, 27 FINOHTA
[4]   Complication rates of invasive intrauterine procedures in a centre for praenatal diagnosis and therapy [J].
Bettelheim, D ;
Kolinek, B ;
Schaller, A ;
Bernaschek, G .
ULTRASCHALL IN DER MEDIZIN, 2002, 23 (02) :119-122
[5]  
Bricker L, 2000, HEALTH TECHNOL ASSES, V4, P1
[6]  
CONNOR JM, 1995, ESSENTIAL MED GENETI
[7]  
CUCKLE HS, 1984, LANCET, V1, P926
[8]   The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study [J].
Grandjean, H ;
Larroque, D ;
Levi, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (02) :446-454
[9]   Sensitivity of routine ultrasound screening of pregnancies in the Eurofetus database [J].
Grandjena, H ;
Larroque, D ;
Levi, S .
ULTRASOUND SCREENING FOR FETAL ANOMALIES: IS IT WORTH IT?: SCREENING REVISITED AFTER THE EUROFETUS DATA, 1998, 847 :118-124
[10]  
Ritchie K, 2004, ROUTINE ULTRASOUND S